170 related articles for article (PubMed ID: 7543503)
1. Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airways.
Svensson C; Grönneberg R; Andersson M; Alkner U; Andersson O; Billing B; Gilljam H; Greiff L; Persson CG
J Allergy Clin Immunol; 1995 Aug; 96(2):239-46. PubMed ID: 7543503
[TBL] [Abstract][Full Text] [Related]
2. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
Greiff L; Persson CG; Svensson C; Enander I; Andersson M
J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
[TBL] [Abstract][Full Text] [Related]
4. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma.
Salomonsson P; Grönneberg R; Gilljam H; Andersson O; Billing B; Enander I; Alkner U; Persson CG
Am Rev Respir Dis; 1992 Dec; 146(6):1535-42. PubMed ID: 1456571
[TBL] [Abstract][Full Text] [Related]
5. Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 hours but not at 5 minutes after challenge.
Nocker RE; van der Zee JS; Weller FR; van Overveld FJ; Jansen HM; Out TA
J Lab Clin Med; 1999 Jul; 134(1):74-82. PubMed ID: 10402062
[TBL] [Abstract][Full Text] [Related]
6. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Alkner U; Persson CG
Clin Exp Allergy; 1995 Oct; 25(10):942-50. PubMed ID: 8556565
[TBL] [Abstract][Full Text] [Related]
7. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
8. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
[TBL] [Abstract][Full Text] [Related]
9. Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen.
Jacobi HH; Skov PS; Kampen GT; Poulsen LK; Reimert CM; Bindslev-Jensen C; Praetorius C; Malling HJ; Mygind N
Clin Exp Allergy; 1998 Jan; 28(1):83-91. PubMed ID: 9537785
[TBL] [Abstract][Full Text] [Related]
10. Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis.
Meyer P; Persson CG; Andersson M; Wollmer P; Linden M; Svensson C; Greiff L
Eur Respir J; 1999 Mar; 13(3):633-7. PubMed ID: 10232439
[TBL] [Abstract][Full Text] [Related]
11. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement.
Koskela H; Di Sciascio MB; Anderson SD; Andersson M; Chan HK; Gadalla S; Katelaris C
Clin Exp Allergy; 2000 Nov; 30(11):1627-36. PubMed ID: 11069573
[TBL] [Abstract][Full Text] [Related]
12. Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds.
Greiff L; Andersson M; Svensson C; Linden M; Myint S; Persson CG
Eur Respir J; 1999 Jan; 13(1):41-7. PubMed ID: 10836321
[TBL] [Abstract][Full Text] [Related]
13. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.
van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R
Clin Exp Allergy; 2002 Oct; 32(10):1448-53. PubMed ID: 12372124
[TBL] [Abstract][Full Text] [Related]
14. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
Andersson M; Greiff L; Wollmer P
Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical capsaicin in seasonal allergic rhinitis.
Greiff L; Svensson C; Andersson M; Persson CG
Thorax; 1995 Mar; 50(3):225-9. PubMed ID: 7660332
[TBL] [Abstract][Full Text] [Related]
16. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses.
Greiff L; Meyer P; Svensson C; Persson CG; Andersson M
Pediatr Allergy Immunol; 1997 Aug; 8(3):137-42. PubMed ID: 9532254
[TBL] [Abstract][Full Text] [Related]
17. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
18. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
19. Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge tests.
Raulf-Heimsoth M; Wirtz C; Papenfuss F; Baur X
Clin Exp Allergy; 2000 Jan; 30(1):110-21. PubMed ID: 10606938
[TBL] [Abstract][Full Text] [Related]
20. Nasal mucosal endorgan hyperresponsiveness.
Svensson C; Andersson M; Greiff L; Persson CG
Am J Rhinol; 1998; 12(1):37-43. PubMed ID: 9513658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
